What Is Your Sickle Cell Disease Management Plan?

Dr. Ify Osunkwo of Levine Cancer Institute/Atrium Health discusses what patients can expect related to sickle cell disease management in the near future. Dr. Osunkwo emphasizes the importance of patients being proactive with their disease management plan in order to maximize quality of life and the effects on one's mortality while living with sickle cell disease (SCD).

Director of the Sickle Cell Disease Enterprise, Levine Cancer Institute, ASH 2019 Sickle Cell, SCD pain, SCD physical, SCD, acute pain episode, premature mortality, sickle cell disease management plan, Ify Osunkwo

About this expert

Ifeyinwa (Ify) Osunkwo, MD, MPH

Director of the Sickle Cell Disease Enterprise

Levine Cancer Institute, Atrium Health

Transcript

Q: What can patients expect related to sickle cell disease management in the near future?


Dr. Osunkwo
So, our patients should expect that we will begin to talk to them about, “What is your disease management plan?” I want to start a campaign about, “You need to have a disease management plan, no matter what genotype you have. What are you doing to treat your disease regardless of whether you have pain?” 


Dr. Osunkwo:

There is a misconception that if you don’t have a lot of pain crisis, you don’t have severe Sickle Cell disease -- but I have patients who have had no pain episodes, but they’ve had a stroke, they have had liver damage, they have pulmonary hypertension, they have leg ulcers. And they may be well for 20-30 years and then they start getting sicker in their 30s and 40s, and they still have a premature mortality. And so, patients should expect to be asked and to be engaged in the conversation around, “Be proactive to develop with your provider a disease management plan that will take care of you for the long term.” Just like for diabetes, you wouldn’t say wait until your sugar is in the 600s to get treatment. You want to catch things early and really control the effect it has on your body and on your mortality.

 

Related Content

pavlos_msaouel.jpg.resize.405.575_edited

Microcosms of Injustice Found Throughout Sickle Cell Disease

Dr. Campbell describes the inequities and injustices throughout the sickle cell community. He presents an example of a patient who almost died because she was not listened to. Physicians must listen to patients with sickle cell disease because their complaints may be a preceding symptom of severe complications.

pavlos_msaouel.jpg.resize.405.575_edited

Is Sickle Cell Disease a Genetic Defense Against COVID-19?

Dr. Msaouel answers questions from the Sickle Cell community. If the disease or trait evolved as a defense against Malaria, does the reported effectiveness of anti-malaria drugs like hydroxychloroquine (Plaquenil) mean that sickle cell patients have natural resistance to the novel coronavirus, COVID-19?

pavlos_msaouel.jpg.resize.405.575_edited

Are Sickle Cell Disease Patients More Susceptible to Renal Medullary Carcinoma?

Dr. Pavlos Msaouel of The University of Texas MD Anderson Cancer Center discusses whether patients with sickle cell disease or who carry the sickle cell trait may be at increased risk for renal medullary carcinoma (RMC).

The information on Diverse Health Hub is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the expert advice of your healthcare team.

© 2020 Diverse Health Hub